In a recent prospective study of 33 patients with deep venous thrombosis, one of the serious complications of BD, the relapse rate was lower and recanalization rate was higher in patients treated with IFN-α compared with AZA (12% vs. 45% and 86% vs. 45%) [104]. The gene discussed is IFNA1; the disease is Behcet disease.